Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38820500

Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2024 Sep 5
First author
Smith MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2024 Sep 5;144(10):1033-1035. doi: 10.1182/blood.2024025289.
    note
    Source null
    related pmid
    39235798
    relationship
    Comment in

Authors and identifiers

  1. name
    Smith MR
    type
    Author
  2. name
    Jegede OA
    type
    Author
  3. name
    Martin P
    type
    Author
  4. name
    Till BG
    type
    Author
  5. name
    Parekh SS
    type
    Author
  6. name
    Yang DT
    type
    Author
  7. name
    Hsi ED
    type
    Author
  8. name
    Witzig T
    type
    Author
  9. name
    Dave S
    type
    Author
  10. name
    Scott D
    type
    Author
  11. name
    Hanson C
    type
    Author
  12. name
    Kostakoglu Shields L
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Smith MR
    type
    Author
  2. name
    Jegede OA
    type
    Author
  3. name
    Martin P
    type
    Author
  4. name
    Till BG
    type
    Author
  5. name
    Parekh SS
    type
    Author
  6. name
    Yang DT
    type
    Author
  7. name
    Hsi ED
    type
    Author
  8. name
    Witzig T
    type
    Author
  9. name
    Dave S
    type
    Author
  10. name
    Scott D
    type
    Author
  11. name
    Hanson C
    type
    Author
  12. name
    Kostakoglu Shields L
    type
    Author
bibliography ids
  1. nci-bib-75fa3cc76990911f93bb5e17
book metadata
content sha256
21bbec0db497799ddd944a58030e5e75e9b4b9233d94c960bd2a97ed7cf57eae
document type
citation
dois
  1. 10.1182/blood.2024023962
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:38820500
immutable id
pubmed:38820500@21bbec0db497799ddd944a58030e5e75e9b4b9233d94c960bd2a97ed7cf57eae
journal
abbreviation
Blood
issn electronic
1528-0020
issn print
0006-4971
issue
10
name
Blood
nlm unique id
7603509
pages
1083-1092
volume
144
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Blood. 2024 Sep 5;144(10):1033-1035. doi: 10.1182/blood.2024025289.
    note
    Source null
    related pmid
    39235798
    relationship
    Comment in
outcomes validated
false
pmid
38820500
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
70874140c571026dec370651dbf6418d4bc3effc0ffa66872e15eb2d8406aa15
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Sep 5
precision
day
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase II
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
  6. Research Support, N.I.H., Extramural
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38820500/
title
Randomized study of induction with bendamustine-rituximab ± bortezomib and maintenance with rituximab ± lenalidomide for MCL.

Preserved source evidence · Not medical advice